These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 35878420)

  • 21. Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles.
    Gardey E; Cseresnyes Z; Sobotta FH; Eberhardt J; Haziri D; Grunert PC; Kuchenbrod MT; Gruschwitz FV; Hoeppener S; Schumann M; Gaßler N; Figge MT; Stallmach A; Brendel JC
    Small; 2024 May; 20(21):e2306482. PubMed ID: 38109123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.
    Guzzo GL; Andrews JM; Weyrich LS
    Inflamm Bowel Dis; 2022 Jul; 28(7):1112-1122. PubMed ID: 35092426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in carbohydrate-based nanoparticles for targeted therapy of inflammatory bowel diseases: A review.
    Liang W; Zhang W; Tian J; Zhang X; Lv X; Qu A; Chen J; Wu Z
    Int J Biol Macromol; 2024 Nov; 281(Pt 4):136392. PubMed ID: 39423983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease.
    Liu W; Dong Z; Liu K; Lu Y; Wu W; Qi J; Chen Z
    Int J Pharm; 2021 May; 600():120461. PubMed ID: 33711470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnology in the Treatment of Inflammatory Bowel Disease.
    Giron F; Pastó A; Tasciotti E; Abraham BP
    Inflamm Bowel Dis; 2019 Nov; 25(12):1871-1880. PubMed ID: 31560054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease.
    Li S; Xie A; Li H; Zou X; Zhang Q
    J Control Release; 2019 Dec; 316():66-78. PubMed ID: 31682913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?
    Moulton CD; Pavlidis P; Norton C; Norton S; Pariante C; Hayee B; Powell N
    Clin Exp Immunol; 2019 Sep; 197(3):308-318. PubMed ID: 30762873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment.
    Wang CJ; Byun MJ; Kim SN; Park W; Park HH; Kim TH; Lee JS; Park CG
    J Control Release; 2022 May; 345():1-19. PubMed ID: 35227764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease.
    Zeeshan M; Ali H; Khan S; Khan SA; Weigmann B
    Int J Pharm; 2019 Mar; 558():201-214. PubMed ID: 30615925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology in the treatment of inflammatory bowel diseases.
    Viscido A; Capannolo A; Latella G; Caprilli R; Frieri G
    J Crohns Colitis; 2014 Sep; 8(9):903-18. PubMed ID: 24686095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.
    Zhang S; Langer R; Traverso G
    Nano Today; 2017 Oct; 16():82-96. PubMed ID: 31186671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel drug delivery systems for inflammatory bowel disease.
    Yasmin F; Najeeb H; Shaikh S; Hasanain M; Naeem U; Moeed A; Koritala T; Hasan S; Surani S
    World J Gastroenterol; 2022 May; 28(18):1922-1933. PubMed ID: 35664964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases.
    Deng Z; Liu S
    Drug Deliv Transl Res; 2021 Aug; 11(4):1475-1497. PubMed ID: 33860447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems.
    Hadji H; Bouchemal K
    Adv Drug Deliv Rev; 2022 Feb; 181():114101. PubMed ID: 34999122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.
    Aleksandrova K; Romero-Mosquera B; Hernandez V
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine.
    Li W; Li Y; Liu Z; Kerdsakundee N; Zhang M; Zhang F; Liu X; Bauleth-Ramos T; Lian W; Mäkilä E; Kemell M; Ding Y; Sarmento B; Wiwattanapatapee R; Salonen J; Zhang H; Hirvonen JT; Liu D; Deng X; Santos HA
    Biomaterials; 2018 Dec; 185():322-332. PubMed ID: 30267958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.